EMERGEN-BioInfo The digital platform for the French SARS-CoV-2 genomic surveillance and research program
authors
keywords
- SARS-CoV-2
- COVID-19
- Genomic surveillance
- Health data
- EMERGEN-Bioinfo
document type
ARTabstract
We present EMERGEN-Bioinfo, the digital platform to collect, process, manage and divulgate viral sequences and non-sensitive metadata, developed in the context of EMERGEN, the French plan for COVID-19 genomic surveillance and research. The bioinformatics platform relies on different components to manage all the steps from raw sequence collection to deposition in international repositories. This includes: (1) specific storage spaces for each one of the 60 teams of the consortium; (2) a data lake gathering all sequences (raw, mapped, consensus genomes, aligned genomic and peptidic sequences); (3) system-level workflows to handle the data flow trough all the components of the platform; (4) a covid-19 specific domain of the national Galaxy server (covid19.usegalaxy.fr); (5) EMERGEN-DB, a database to store and manage non-sensitive metadata and genomic consensus sequences ; (6) data brokering services to facilitate metadata management and curation, submission to international repositories (GISAID and ENA) and follow-up of their acceptance status. The EMERGEN-Bioinfo platform is complemented by a high-security digital platform (EMERGEN-HDS) certified for Health Data Storage, which will enable researchers to pair EMERGEN data with patient data from different sources (national COVID-19 and healthcare databases). All the software resources developed for this projects will be accessible under an open license, and re-usable for other national projects (e.g. ABRomics multi-omics platform for surveillance and research on antimicrobial resistance) or international cooperation (e.g. sharing with partners of the European bioinformatics infrastructure ELIXIR).
